Sinovac supplier Pharmaniaga Q2 revenue, earnings soar

KUALA LUMPUR: Pharmaniaga Bhd said its revenue soared 82% to RM1.18bil in the second quarter boosted by sales of Sinovac Covid-19 vaccine to the government.

Net profit rose 37% to RM13.7mil in the three-month ended June 30, the company said in a filing with Bursa Malaysia today. Pharmaniaga has declared a second interim dividend of 1.5 sen a share.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , Sinovac

Next In Business News
Wawasan Dengkil and Kester partner on renewable energy projects
Binastra's unit inks tripartite agreement involving RM305mil contract
Ringgit ends lower as firmer US dollar weighs on market
Infomina posts higher 2Q profit, declares 1.35 sen dividend
SkyGate acquires property investment firm for RM76mil
Berjaya Land proposes name change to Berjaya Property
SCIB shareholders approve rights issue, share capital reduction
SC Estate Builder to acquire 25% stake in non-operational hotel for RM18.79mil
FBM KLCI on a roll, notches fifth straight gain
China central bank to cut some sector-specific rates to boost economy

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.